Recipharm

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40009892

Informations générales

Localisation

Sweden

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

08/02/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Recipharm commits to reduce absolute scope 1 and 2 GHG emissions 42.1% by 2030 from a 2021 base year*. Recipharm also commits to increase active annual sourcing of renewable electricity from 93.5% in 2021 to 100.0% by 2030. Recipharm also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel and energy related activities, upstream transportation and distribution, waste generated in operations, business travel, employee commuting, use of sold products, and end of life treatment of sold products 25.0% within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques